2013Journal of Qiqihar University of MedicineRequires access

Study of Trazodone in treating late-onset patients with depression

X Wang

Open publisher page 0 citations

Abstract

Objective To investigate the efficacy and safety of Trazdone in the treatment of late-onset patients with depression.Methods 60 late-onset patients with depression were divided into two groups.They were assigned to receive Trazdone or Citalopram.All patients were observed for 6 weeks.The patients were assessed with Hamilton depressive scale(HAMD),clinical global impression(CGI)and treatment emergent symptom scale(TESS).Results The efficacy of both drugs had no significant differences in the scores of hamilton depressive scale and clinical global impression(P0.05).Trazdone had less side effects than Citalopram.Conclusions Trazdone is a safe and effective drug for late-onset depressive with more rapid onset of action and less side effects than Citalopram.

About this research paper

What this paper is about

Objective To investigate the efficacy and safety of Trazdone in the treatment of late-onset patients with depression.Methods 60 late-onset patients with depression were divided into two groups.They were assigned to receive Trazdone or Citalopram.All patients were observed for 6 weeks.The patients were assessed with Hamilton depressive scale(HAMD),clinical global impression(CGI)and treatment emergent symptom scale(TESS).Results The efficacy of both drugs had no significant differences in the scores of hamilton depressive scale and clinical global impression(P0.05).Trazdone had less side effects than Citalopram.Conclusions Trazdone is a safe and effective drug for late-onset depressive with more rapid onset of action and less side effects than Citalopram.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the efficacy and safety of Trazdone in the treatment of late-onset patients with depression.Methods 60 late-onset patients with depression were divided into two groups.They were assigned to receive Trazdone or Citalopram.All patients were observed for 6 weeks.The patients were assessed with Hamilton depressive scale(HAMD),clinical global impression(CGI)and treatment emergent symptom scale(TESS).Results The efficacy of both drugs had no significant differences in the scores of hamilton depressive scale and clinical global impression(P0.05).Trazdone had less side effects than Citalopram.Conclusions Trazdone is a safe and effective drug for late-onset depressive with more rapid onset of action and less side effects than Citalopram.

Key concepts: Citalopram, Medicine, Clinical Global Impression, Hamd, Trazodone, Depression (economics), Hamilton depression scale, Internal medicine

Related papers

Back to paper searchBrowse research topicsOriginal source
Study of Trazodone in treating late-onset patients with depression — Research Paper | ScholarLens